The Policy, and Politics, of Medicare Advantage

The Host

Medicare Benefit, the private-sector different to unique Medicare, now enrolls practically half of all Medicare beneficiaries. But it surely stays controversial as a result of — whereas most of its subscribers like the additional advantages many plans present — this system continuously prices the federal authorities greater than if these seniors remained within the absolutely public program. That controversy is turning into political, because the Biden administration tries to rein in a few of these funds with out being accused of “chopping” Medicare.

In the meantime, President Joe Biden has signed a invoice to declassify U.S. intelligence concerning the attainable origin of covid-19 in China. And new proof has emerged doubtlessly linking the virus to raccoon canine at an animal market in Wuhan, the place the virus reportedly first took maintain.

This week’s panelists are Julie Rovner of KHN, Margot Sanger-Katz of The New York Instances, Jessie Hellmann of CQ Roll Name, and Joanne Kenen of the Johns Hopkins Bloomberg Faculty of Public Well being and Politico.

Among the many takeaways from this week’s episode:

• The Biden administration just lately modified the components used to calculate how a lot the federal authorities pays personal Medicare Benefit plans to take care of sufferers with severe situations, amid allegations that lots of the well being plans overcharge and even defraud the federal government. Main insurers are making no secret about how profitable this system could be: Humana just lately mentioned it might depart the business insurance coverage market and give attention to government-funded applications, like its booming Medicare Benefit plans.
• The components change is meant to rein in extra spending on Medicare — an enormous, pricey program liable to insolvency — but it has triggered a lobbying blitz, together with a vigorous letter-writing marketing campaign in assist of the favored Medicare Benefit program. On Capitol Hill, although, social gathering leaders haven’t stepped as much as defend personal insurers as aggressively as they’ve up to now. However the 2024 marketing campaign season might hear the events buying and selling accusations over whether or not Biden lower Medicare or, conversely, protected it.
• The most recent maternal mortality charges launched by the Facilities for Illness Management and Prevention present the issue continued to worsen through the pandemic. Many states have prolonged Medicaid protection for a full 12 months after girls give beginning, in an effort to enhance care throughout that higher-risk interval. However different issues restrict entry to postpartum care. Throughout the pandemic, some girls didn’t get prenatal care. And after the autumn of Roe v. Wade, some states are having bother securing suppliers — together with one rural Idaho hospital, which introduced it can cease delivering infants.
• The federal authorities will quickly declassify intelligence associated to the origins of the covid pandemic. In america, the combat over what began the pandemic has largely morphed into a problem of political id, with Republicans favoring the notion {that a} Chinese language lab leak began the worldwide well being disaster that killed tens of millions, whereas Democrats usually tend to consider it was animal transmission tied to a moist market.
• And in drug value information, Sanofi has grow to be the third main insulin maker (of three) to announce it can scale back the value on a few of its insulin merchandise forward of a U.S. authorities coverage change subsequent 12 months that might have value the corporate.

Plus, for “additional credit score,” the panelists counsel well being coverage tales they learn this week that they suppose you need to learn, too:

Julie Rovner: Vice Information’ “Contained in the Personal Group The place Dad and mom Give Ivermectin to Children With Autism,” by David Gilbert

Jessie Hellmann: The Washington Put up’s “Senior Care Is Crushingly Costly. Boomers Aren’t Prepared,” by Christopher Rowland

Joanne Kenen: The New Yorker’s “Will the Ozempic Period Change How We Assume About Being Fats and Being Skinny?” by Jia Tolentino

Margot Sanger-Katz: Slate’s “You Know What? I’m Not Doing This Anymore,” by Sophie Novack

Additionally talked about on this week’s podcast:

To listen to all our podcasts, click on right here.

And subscribe to KHN’s What the Well being? on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you hearken to podcasts.